Two of the world's largest pharmaceutical companies are suing Oklahoma to stop a new state law dealing with a $70 billion ...

The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic ...

Former Senate HELP ranker Richard Burr has pulled in yet another new lobbying client from the pharmaceuticals world.

Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...

More medicines will be spared from Medicare price negotiations, a change that is projected to wipe out billions in savings ...

There are several reasons why switching to a new Medicare Part D plan is a smart move. A good Part D prescription drug plan covers what you need to stay healthy without breaking the bank.

Employers have absorbed the majority of cost increases over the past four years, and they likely cannot continue to do so,” ...

Dive Insight: The Center for Medicare and Medicaid Innovation will oversee WISeR, which will run for six years, between Jan. 1, 2026, and Dec. 31, 2031.

Canada is the primary supplier to India of peas of lentils; two of the country’s most critical food staples. Canola, one of ...

Artificial intelligence (AI) has the potential to transform several different areas of the healthcare industry.

A clinical guidance from the American College of Cardiology Solution Set Oversight Committee states that pharmacotherapy may ...

Vital chemotherapy drugs used around the world have failed quality tests, putting cancer patients in more than 100 countries at risk of ineffective treatments and potentially fatal side effects, an ...